Literature DB >> 21385949

Amine-reactive OVA multimers for auto-vaccination against cytokines and other mediators: perspectives illustrated for GCP-2 in L. major infection.

Catherine Uyttenhove1, Reece G Marillier, Fabienne Tacchini-Cottier, Mélanie Charmoy, Rachel R Caspi, Jesse M Damsker, Stanislas Goriely, Dan Su, Jo Van Damme, Sofie Struyf, Ghislain Opdenakker, Jacques Van Snick.   

Abstract

Anticytokine auto-vaccination is a powerful tool for the study of cytokine functions in vivo but has remained rather esoteric as a result of numerous technical difficulties. We here describe a two-step procedure based on the use of OVA multimers purified by size exclusion chromatography after incubation with glutaraldehyde at pH 6. When such polymers are incubated with a target protein at pH 8.5 to deprotonate reactive amines, complexes are formed that confer immunogenicity to self-antigens. The chemokine GCP-2/CXCL6, the cytokines GM-CSF, IL-17F, IL-17E/IL-25, IL-27, and TGF-β1, and the MMP-9/gelatinase B are discussed as examples. mAb, derived from such immunized mice, have obvious advantages for in vivo studies of the target proteins. Using a mAb against GCP-2, obtained by the method described here, we provide the first demonstration of the major role played by this chemokine in rapid neutrophil mobilization after Leishmania major infection. Pre-activated OVA multimers reactive with amine residues thus provide an efficient carrier for auto-vaccination against 9-90 kDa autologous proteins.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21385949      PMCID: PMC3157325          DOI: 10.1189/jlb.1210699

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  35 in total

1.  Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis.

Authors:  Catherine Uyttenhove; Jacques Van Snick
Journal:  Eur J Immunol       Date:  2006-11       Impact factor: 5.532

2.  Active immunization of heifers against luteinizing hormone-releasing hormone, human chorionic gonadotropin and bovine luteinizing hormone.

Authors:  H E Johnson; D M DeAvila; C F Chang; J J Reeves
Journal:  J Anim Sci       Date:  1988-03       Impact factor: 3.159

3.  An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct.

Authors:  M Abe; J G Harpel; C N Metz; I Nunes; D J Loskutoff; D B Rifkin
Journal:  Anal Biochem       Date:  1994-02-01       Impact factor: 3.365

4.  Therapeutic antibodies elicited by immunization against TNF-alpha.

Authors:  I Dalum; D M Butler; M R Jensen; P Hindersson; L Steinaa; A M Waterston; S N Grell; M Feldmann; H I Elsner; S Mouritsen
Journal:  Nat Biotechnol       Date:  1999-07       Impact factor: 54.908

5.  Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells.

Authors:  Marcel Batten; Ji Li; Sothy Yi; Noelyn M Kljavin; Dimitry M Danilenko; Sophie Lucas; James Lee; Frederic J de Sauvage; Nico Ghilardi
Journal:  Nat Immunol       Date:  2006-08-13       Impact factor: 25.606

6.  Identification of mouse granulocyte chemotactic protein-2 from fibroblasts and epithelial cells. Functional comparison with natural KC and macrophage inflammatory protein-2.

Authors:  A Wuyts; A Haelens; P Proost; J P Lenaerts; R Conings; G Opdenakker; J Van Damme
Journal:  J Immunol       Date:  1996-08-15       Impact factor: 5.422

7.  VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases.

Authors:  Farhad Haghighi Rad; Hélène Le Buanec; Sébastien Paturance; Patrick Larcier; Philippe Genne; Bernhard Ryffel; Armand Bensussan; Bernard Bizzini; Robert C Gallo; Daniel Zagury; Georges Uzan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-14       Impact factor: 11.205

8.  Breaking of B cell tolerance toward a highly conserved self protein.

Authors:  I Dalum; M R Jensen; P Hindersson; H I Elsner; S Mouritsen
Journal:  J Immunol       Date:  1996-12-01       Impact factor: 5.422

9.  Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis.

Authors:  Gunther Spohn; Iris Keller; Markus Beck; Paula Grest; Gary T Jennings; Martin F Bachmann
Journal:  Eur J Immunol       Date:  2008-03       Impact factor: 5.532

10.  Development of an anti-IL-12 p40 auto-vaccine: protection in experimental autoimmune encephalomyelitis at the expense of increased sensitivity to infection.

Authors:  Catherine Uyttenhove; Berenice Arendse; Vincent Stroobant; Frank Brombacher; Jacques Van Snick
Journal:  Eur J Immunol       Date:  2004-12       Impact factor: 5.532

View more
  12 in total

1.  Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression.

Authors:  Ludovic Belle; Kimberle Agle; Vivian Zhou; Cheng Yin-Yuan; Richard Komorowski; Daniel Eastwood; Brent Logan; Jie Sun; Nico Ghilardi; Daniel Cua; Calvin B Williams; Melanie Gaignage; Reece Marillier; Jacques van Snick; William R Drobyski
Journal:  Blood       Date:  2016-08-03       Impact factor: 22.113

2.  Distinct subunit pairing criteria within the heterodimeric IL-12 cytokine family.

Authors:  Lindsay L Jones; Vandana Chaturvedi; Catherine Uyttenhove; Jacques Van Snick; Dario A A Vignali
Journal:  Mol Immunol       Date:  2012-04-07       Impact factor: 4.407

3.  TLR2 Signaling in Skin Nonhematopoietic Cells Induces Early Neutrophil Recruitment in Response to Leishmania major Infection.

Authors:  Catherine Ronet; Katiuska Passelli; Mélanie Charmoy; Leo Scarpellino; Elmarie Myburgh; Yazmin Hauyon La Torre; Salvatore Turco; Jeremy C Mottram; Nicolas Fasel; Sanjiv A Luther; Stephen M Beverley; Pascal Launois; Fabienne Tacchini-Cottier
Journal:  J Invest Dermatol       Date:  2018-12-27       Impact factor: 8.551

4.  Mouse nidovirus LDV infection alleviates graft versus host disease and induces type I IFN-dependent inhibition of dendritic cells and allo-responsive T cells.

Authors:  Mélanie Gaignage; Reece G Marillier; Catherine Uyttenhove; Nicolas Dauguet; Anubha Saxena; Bernard Ryffel; Thomas Michiels; Jean-Paul Coutelier; Jacques Van Snick
Journal:  Immun Inflamm Dis       Date:  2017-04-04

5.  GM-CSF targeted immunomodulation affects host response to M. tuberculosis infection.

Authors:  Sulayman Benmerzoug; Fabio Vitarelli Marinho; Stéphanie Rose; Claire Mackowiak; David Gosset; Delphine Sedda; Emeline Poisson; Catherine Uyttenhove; Jacques Van Snick; Muazzam Jacobs; Irene Garcia; Bernhard Ryffel; Valerie F J Quesniaux
Journal:  Sci Rep       Date:  2018-06-05       Impact factor: 4.379

6.  The TLR7 ligand R848 prevents mouse graft-versus-host disease and cooperates with anti-interleukin-27 antibody for maximal protection and regulatory T-cell upregulation.

Authors:  Mélanie Gaignage; Reece G Marillier; Perrine M Cochez; Laure Dumoutier; Catherine Uyttenhove; Jean-Paul Coutelier; Jacques Van Snick
Journal:  Haematologica       Date:  2018-09-13       Impact factor: 9.941

7.  Fibrogenesis in Chronic DSS Colitis is Not Influenced by Neutralisation of Regulatory T Cells, of Major T Helper Cytokines or Absence of IL-13.

Authors:  Brecht Creyns; Jonathan Cremer; Tomoaki Hoshino; Karel Geboes; Gert de Hertogh; Marc Ferrante; Séverine Vermeire; Jan L Ceuppens; Gert Van Assche; Christine Breynaert
Journal:  Sci Rep       Date:  2019-07-11       Impact factor: 4.379

8.  TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism.

Authors:  Stefania Canè; Jacques Van Snick; Catherine Uyttenhove; Luc Pilotte; Benoit J Van den Eynde
Journal:  J Immunother Cancer       Date:  2021-02       Impact factor: 13.751

Review 9.  The Impact of Neutrophil Recruitment to the Skin on the Pathology Induced by Leishmania Infection.

Authors:  Katiuska Passelli; Oaklyne Billion; Fabienne Tacchini-Cottier
Journal:  Front Immunol       Date:  2021-03-01       Impact factor: 7.561

10.  Does T Helper Differentiation Correlate with Resistance or Susceptibility to Infection with L. major? Some Insights From the Murine Model.

Authors:  Fabienne Tacchini-Cottier; Tiffany Weinkopff; Pascal Launois
Journal:  Front Immunol       Date:  2012-02-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.